Healthcare provider profile · identity verified

Anuradha Gowda, MD

Internal Medicine · PITTSBURGH, PA · NPI 1164459699

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	304	83
Amlodipine Besylate	Amlodipine Besylate	267	79
Levothyroxine Sodium	Levothyroxine Sodium	260	72
Lisinopril	Lisinopril	194	59
Metoprolol Succinate	Metoprolol Succinate	142	45
Pantoprazole Sodium	Pantoprazole Sodium	121	47
Metoprolol Tartrate	Metoprolol Tartrate	118	38
Metformin Hcl	Metformin Hcl	113	36
Simvastatin	Simvastatin	102	28
Meloxicam	Meloxicam	89	33
Famotidine	Famotidine	87	29
Gabapentin	Gabapentin	86	21
Furosemide	Furosemide	85	38
Hydrochlorothiazide	Hydrochlorothiazide	84	26
Omeprazole	Omeprazole	83	24
Losartan Potassium	Losartan Potassium	77	25
Trazodone Hcl	Trazodone Hcl	75	20
Rosuvastatin Calcium	Rosuvastatin Calcium	73	26
Eliquis	Apixaban	72	25
Clopidogrel	Clopidogrel Bisulfate	62	20
Jardiance	Empagliflozin	62	suppressed
Amoxicillin	Amoxicillin	61	48
Ozempic	Semaglutide	59	12
Sertraline Hcl	Sertraline Hcl	57	18
Pravastatin Sodium	Pravastatin Sodium	56	18
Carvedilol	Carvedilol	54	16
Albuterol Sulfate Hfa	Albuterol Sulfate	51	18
Atenolol	Atenolol	51	17
Montelukast Sodium	Montelukast Sodium	50	15
Potassium Chloride	Potassium Chloride	48	17
Methylprednisolone	Methylprednisolone	47	36
Entresto	Sacubitril/Valsartan	46	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	16
Duloxetine Hcl	Duloxetine Hcl	42	13
Donepezil Hcl	Donepezil Hcl	37	13
Tamsulosin Hcl	Tamsulosin Hcl	37	suppressed
Azithromycin	Azithromycin	36	28
Synthroid	Levothyroxine Sodium	35	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Celecoxib	Celecoxib	24	12
Glimepiride	Glimepiride	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Topiramate	Topiramate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Valsartan	Valsartan	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Glipizide	Glipizide	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Calcium Acetate	Calcium Acetate	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Prednisone	Prednisone	13	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Doxycycline Hyclate	Doxycycline Hyclate	12	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error